📊 CIRX Key Takeaways
Investment Thesis
Cirtran Corp exhibits severe financial distress with negative stockholders' equity of -$25.5M, indicating the company is technically insolvent. The company is burning cash at an alarming rate with -$1.0M operating cash flow on just $1.1M revenue, while maintaining $27.5M in total liabilities that far exceed its $1.9M asset base. Revenue has contracted 19.8% YoY and the company is not generating sustainable operations.
CIRX Strengths
- Maintains 49.5% gross margin, suggesting potential in product profitability if scaled efficiently
- Generated $533.1K in gross profit despite operational losses
- Minimal insider selling activity (0 Form 4 filings in last 90 days) shows limited confidence but no panic exits
CIRX Risks
- Negative equity position of -$25.5M creates existential solvency risk and potential equity wipeout
- Critical liquidity crisis with current ratio of 0.07x and only $19.3K cash against $27.5M liabilities
- Severe operating cash burn of -$1.0M annually combined with declining revenue (-19.8% YoY) makes near-term survival questionable
- Negative interest coverage of -2.2x indicates inability to service debt obligations from operations
- Operating losses of -$403.0K and net losses of -$1.1M suggest business model is fundamentally broken
Key Metrics to Watch
- Cash depletion rate and runway before insolvency
- Ability to refinance or restructure $27.5M liabilities
- Revenue trend reversal and path to positive operating cash flow
- Stockholders' equity recovery and deleveraging progress
CIRX Financial Metrics
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
CIRX Profitability Ratios
CIRX vs Default Sector
How CIRTRAN CORP compares to Default sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
CIRX Balance Sheet & Liquidity
CIRX 5-Year Financial Trend
5-Year Trend Summary: CIRTRAN CORP's revenue has remained relatively flat over the 5-year period, with a 7% decline. The most recent EPS of $4.10 reflects profitable operations.
CIRX Growth Metrics (YoY)
CIRX Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $256.1K | -$155.4K | $-0.09 |
| Q2 2025 | $168.4K | -$155.4K | $-0.08 |
| Q1 2025 | $429.4K | -$155.4K | $-0.03 |
| Q3 2024 | $256.1K | -$205.8K | $-0.04 |
| Q2 2024 | $390.5K | -$243.0K | $-0.05 |
| Q1 2024 | $213.4K | -$480.3K | $-0.10 |
| Q3 2023 | $477.0K | -$205.8K | $-0.04 |
| Q2 2023 | $458.5K | -$243.0K | $-0.05 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
CIRX Capital Allocation
CIRX SEC Filings
Access official SEC EDGAR filings for CIRTRAN CORP (CIK: 0000813716)
📋 Recent SEC Filings
❓ Frequently Asked Questions about CIRX
What is the AI rating for CIRX?
CIRTRAN CORP (CIRX) has an AI rating of STRONG SELL with 95% confidence, based on fundamental analysis of SEC EDGAR filings.
What are CIRX's key strengths?
Maintains 49.5% gross margin, suggesting potential in product profitability if scaled efficiently. Generated $533.1K in gross profit despite operational losses.
What are the risks of investing in CIRX?
Negative equity position of -$25.5M creates existential solvency risk and potential equity wipeout. Critical liquidity crisis with current ratio of 0.07x and only $19.3K cash against $27.5M liabilities.
What is CIRX's revenue and growth?
CIRTRAN CORP reported revenue of $1.1M.
Does CIRX pay dividends?
CIRTRAN CORP does not currently pay dividends.
Where can I find CIRX SEC filings?
Official SEC filings for CIRTRAN CORP (CIK: 0000813716) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is CIRX's EPS?
CIRTRAN CORP has a diluted EPS of $-0.23.
How is the AI analysis conducted?
Our AI (Claude) analyzes publicly available SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports to evaluate financial health, profitability ratios, balance sheet strength, and growth metrics.